Home  »  Business   »  The Chart for GreenLight Biosciences Holdings (GRN...

The Chart for GreenLight Biosciences Holdings (GRNA) Is Flashing Mixed Signals

GreenLight Biosciences Holdings (NASDAQ:GRNA) went up by 5.83% from its latest closing price compared to the recent 1-year high of $15.80. The company’s stock price has collected -23.49% of loss in the last five trading sessions.

Is It Worth Investing in GreenLight Biosciences Holdings (NASDAQ :GRNA) Right Now?

Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for GreenLight Biosciences Holdings declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


The average price from analysts is $5.50, which is $4.23 above the current price. GRNA currently public float of 82.68M and currently shorts hold a 2.45% ratio of that float. Today, the average trading volume of GRNA was 459.97K shares.

GRNA’s Market Performance

GRNA stocks went down by -23.49% for the week, with a monthly drop of -33.85% and a quarterly performance of -62.43%, while its annual performance rate touched -87.22%. The volatility ratio for the week stands at 15.31% while the volatility levels for the past 30 days are set at 11.16% for GreenLight Biosciences Holdings. The simple moving average for the period of the last 20 days is -28.71% for GRNA stocks with a simple moving average of -74.17% for the last 200 days.

Analysts’ Opinion of GRNA

Many brokerage firms have already submitted their reports for GRNA stocks, with Credit Suisse repeating the rating for GRNA by listing it as a “Outperform.” The predicted price for GRNA in the upcoming period, according to Credit Suisse is $5.50 based on the research report published on October 14th of the current year 2022.

GRNA Trading at -34.54% from the 50-Day Moving Average

After a stumble in the market that brought GRNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.96% of loss for the given period.

Volatility was left at 11.16%, however, over the last 30 days, the volatility rate increased by 15.31%, as shares sank -36.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.44% lower at present.

During the last 5 trading sessions, GRNA fell by -23.49%, which changed the moving average for the period of 200-days by -85.57% in comparison to the 20-day moving average, which settled at $1.7450. In addition, GreenLight Biosciences Holdings saw -87.20% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GRNA starting from Morningside Venture Investment, who purchase 3,061,224 shares at the price of $3.92 back on Aug 11. After this action, Morningside Venture Investment now owns 15,919,155 shares of GreenLight Biosciences Holdings, valued at $11,999,998 using the latest closing price.

Builders Vision, LLC, the 10% Owner of GreenLight Biosciences Holdings, purchase 6,505,102 shares at $3.92 during a trade that took place back on Aug 11, which means that Builders Vision, LLC is holding 22,348,123 shares at $25,500,000 based on the most recent closing price.

Stock Fundamentals for GRNA

Equity return is now at value -493.90, with -149.60 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.04.